Found: 193
Select item for more details and to access through your institution.
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2755, doi. 10.3390/cancers16152755
- By:
- Publication type:
- Article
Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30‐positive cutaneous T‐cell lymphoma.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 8, p. 1037, doi. 10.1111/1346-8138.17324
- By:
- Publication type:
- Article
Vogt‐Koyanagi‐Harada disease‐like uveitis after drug therapy including BRAF/MEK inhibitors in melanoma patients with HLA‐DRB1*04.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 6, p. 854, doi. 10.1111/1346-8138.17082
- By:
- Publication type:
- Article
Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1365894
- By:
- Publication type:
- Article
Adverse events associated with postoperative outcomes of adjuvant anti‐PD‐1 antibody therapy in both acral and non‐acral cutaneous melanomas: A multicenter, observational, post hoc analysis study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 3, p. 458, doi. 10.1111/1346-8138.16912
- By:
- Publication type:
- Article
CIC-DUX4 Rearranged Sarcoma Presenting in the Skin: Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel‐resistant cutaneous angiosarcoma: Phase II study protocol.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3244
- By:
- Publication type:
- Article
Eruptive milium‐like syringoma: A case report.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 11, p. e377, doi. 10.1111/1346-8138.16887
- By:
- Publication type:
- Article
Postoperative adjuvant therapy for 120 patients with melanoma, including acral and mucosal subtypes: a multicentre, observational study of 2-year follow-up results.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 4, p. 476, doi. 10.1093/bjd/ljad183
- By:
- Publication type:
- Article
Papular interstitial elastolytic giant cell granuloma concomitant with lichen amyloidosus in a type II diabetes patient.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 612, doi. 10.1002/jvc2.180
- By:
- Publication type:
- Article
The significance of M1‐polarized CD163+ macrophages in acute graft‐versus‐host disease (GVHD): Possible mechanisms of GVHD in the development of skin lesions.
- Published in:
- Journal of Cutaneous Immunology & Allergy, 2023, v. 6, n. 4, p. 120, doi. 10.1002/cia2.12304
- By:
- Publication type:
- Article
Acquired idiopathic generalized anhidrosis after novel coronavirus (SARS‐CoV‐2) infection.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 8, p. e245, doi. 10.1111/1346-8138.16771
- By:
- Publication type:
- Article
Treatment for taxane‐resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 7, p. 912, doi. 10.1111/1346-8138.16786
- By:
- Publication type:
- Article
LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated Macrophages.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1678, doi. 10.3390/cancers15061678
- By:
- Publication type:
- Article
Olaparib-Induced Purpuric Drug Eruption in a Patient with Castration-Resistant Prostate Cancer.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 434, doi. 10.1159/000530981
- By:
- Publication type:
- Article
Recurrent, Tumor Mutation Burden-High, Cutaneous Angiosarcoma of the Scalp Treated with Pembrolizumab.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 1490, doi. 10.1159/000534657
- By:
- Publication type:
- Article
Plasminogen activating inhibitor‐1 promotes angiogenesis in cutaneous angiosarcomas.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 1, p. 50, doi. 10.1111/exd.14681
- By:
- Publication type:
- Article
The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 875, doi. 10.3390/ijms24010875
- By:
- Publication type:
- Article
Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15720, doi. 10.3390/ijms232415720
- By:
- Publication type:
- Article
New onset of palmoplantar keratosis triggered by COVID‐19 vaccination.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15937
- By:
- Publication type:
- Article
Cutaneous T cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real‐world case series.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15858
- By:
- Publication type:
- Article
Successful treatment of CD8+ syringotropic mycosis fungoides with bexarotene and local radiotherapy.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15850
- By:
- Publication type:
- Article
Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15736
- By:
- Publication type:
- Article
Serum CCL22 Increased in Advanced Melanoma Patients with Liver Metastases: Report of 5 Cases.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
A pediatric case of corticosteroid‐resistant erosive pustular dermatosis of scalp‐like alopecia treated successfully with oral indomethacin, doxycycline, and topical tacrolimus.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 9, p. e299, doi. 10.1111/1346-8138.16425
- By:
- Publication type:
- Article
Tubulointerstitial Nephritis in an Advanced Melanoma Patient Treated with Encorafenib plus Binimetinib Combination Therapy.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 5, p. e167, doi. 10.1111/1346-8138.16304
- By:
- Publication type:
- Article
Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 4044, doi. 10.3390/ijms23074044
- By:
- Publication type:
- Article
Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 3, p. 1, doi. 10.1111/dth.15290
- By:
- Publication type:
- Article
Safety and efficacy of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: Real‐world experience from post‐marketing surveillance.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 2, p. 253, doi. 10.1111/1346-8138.16201
- By:
- Publication type:
- Article
Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.678
- By:
- Publication type:
- Article
Quantitative Analysis of Immune-Reactive Cells among Leukocytes Is Useful for the Diagnosis of Drug Eruptions Caused by Bexarotene.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.798385
- By:
- Publication type:
- Article
Matrix Metalloproteinase 28-Bearing Microcystic Adnexal Carcinoma on the Back.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Successful treatment of BRAF/MEK inhibitor‐resistant advanced cutaneous melanoma with nivolumab plus ipilimumab combination therapy followed by intensity‐modulated radiotherapy.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 9, p. 1419, doi. 10.1111/1346-8138.15962
- By:
- Publication type:
- Article
Phosphor‐signal transducers and activator of transcription 1 signaling in mucosal lichen planus developing from metastatic bladder cancer treated with pembrolizumab.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 4, p. 1, doi. 10.1111/dth.14961
- By:
- Publication type:
- Article
RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma.
- Published in:
- Pathology International, 2021, v. 71, n. 5, p. 337, doi. 10.1111/pin.13090
- By:
- Publication type:
- Article
Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoid.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 3, p. 353, doi. 10.1111/1346-8138.15713
- By:
- Publication type:
- Article
Case series of BRAF‐mutated advanced melanoma treated with encorafenib plus binimetinib combination therapy.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 3, p. 397, doi. 10.1111/1346-8138.15688
- By:
- Publication type:
- Article
Dabrafenib plus trametinib combination therapy triggered onset of pustulosis palmaris et plantaris in a patient with advanced cutaneous melanoma.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 3, p. e135, doi. 10.1111/1346-8138.15747
- By:
- Publication type:
- Article
Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 2, p. 200, doi. 10.3390/pharmaceutics13020200
- By:
- Publication type:
- Article
Serum soluble CD163 and proinflammatory chemokines may be biomarkers of the onset of adverse events in dabrafenib plus trametinib combination therapy for advanced melanoma.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 1, p. 1, doi. 10.1111/dth.14544
- By:
- Publication type:
- Article
Severe eczematoid and lichenoid eruption with full‐thickness epidermal necrosis developing from metastatic urothelial cancer treated with enfortumab vedotin.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 12, p. 1436, doi. 10.1111/1346-8138.15577
- By:
- Publication type:
- Article
Erythema nodosum developed in a patient with advanced cutaneous melanoma treated with dabrafenib plus trametinib combination therapy.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14430
- By:
- Publication type:
- Article
Serum CCL22 levels decreased in parallel with disease activity in CCR4‐positive mycosis fungoides treated with mogamulizumab.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14099
- By:
- Publication type:
- Article
Multiple angiolymphoid hyperplasia with eosinophilia on the right arm showing unusual presentation.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14314
- By:
- Publication type:
- Article
Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 3, p. 1141, doi. 10.1159/000510261
- By:
- Publication type:
- Article
Treatment of Advanced Melanoma: Past, Present and Future.
- Published in:
- Life (2075-1729), 2020, v. 10, n. 9, p. 208, doi. 10.3390/life10090208
- By:
- Publication type:
- Article